Obesity Clinical Trial
— MAMAO2Official title:
Management of Antipsychotic Medication Associated Obesity - 2
NCT number | NCT01052714 |
Other study ID # | D7358-R |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 1, 2010 |
Est. completion date | May 28, 2015 |
Verified date | July 2018 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This program aims to help Veterans who take antipsychotic medications lose weight. We use a program based on the American Diabetes Association's "Diabetes Prevention Program," and we have modified it to fit the lifestyles of people with mental illness. All participants are educated about nutrition and cutting down fat intake, how and when to exercise, and the causes of diabetes and how to prevent it. Participants must be Veterans who live within one hour of the Long Beach, West Los Angeles, Sepulveda, or West Los Angeles VA hospitals.
Status | Completed |
Enrollment | 121 |
Est. completion date | May 28, 2015 |
Est. primary completion date | May 28, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Must be a Veteran - Diagnosis of psychotic disorders, schizophrenia, schizoaffective disorder and bipolar illness - Age 18-70 - Clinically determined to require ongoing treatment with Second Generation Antipsychotics (SGA) such as olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, clozapine - Experienced weight gain since treatment with SGA's - Inpatient or outpatient at Long Beach, West Los Angeles, Sepulveda, or Downtown VA - Competent to sign informed consent Exclusion Criteria: - Have recently been diagnosed with schizophrenia (less than 1 year) - Are pregnant or breast feeding a baby - Have a medically unstable condition |
Country | Name | City | State |
---|---|---|---|
United States | VA Long Beach Healthcare System, Long Beach, CA | Long Beach | California |
United States | VA Greater Los Angeles Healthcare System, Sepulveda, CA | Sepulveda | California |
United States | VA Greater Los Angeles Healthcare System, West Los Angeles, CA | West Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Erickson ZD, Kwan CL, Gelberg HA, Arnold IY, Chamberlin V, Rosen JA, Shah C, Nguyen CT, Hellemann G, Aragaki DR, Kunkel CF, Lewis MM, Sachinvala N, Sonza PA, Pierre JM, Ames D. A Randomized, Controlled Multisite Study of Behavioral Interventions for Veter — View Citation
Gelberg HA, Kwan CL, Mena SJ, Erickson ZD, Baker MR, Chamberlin V, Nguyen C, Rosen JA, Shah C, Ames D. Meal replacements as a weight loss tool in a population with severe mental illness. Eat Behav. 2015 Dec;19:61-4. doi: 10.1016/j.eatbeh.2015.06.009. Epub 2015 Jul 2. — View Citation
Kwan CL, Gelberg HA, Rosen JA, Chamberlin V, Shah C, Nguyen C, Pierre JM, Erickson ZD, Mena SJ, King M Jr, Arnold I, Baker MR, Meyer HB, Ames D. Nutritional counseling for adults with severe mental illness: key lessons learned. J Acad Nutr Diet. 2014 Mar;114(3):369-74. doi: 10.1016/j.jand.2013.12.005. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean Weight Change Per Week From Baseline to Termination | Participants' weight was measured at each visit by study personnel using hospital scales, and the study groups' average weight changes per week were compared. | Up to 19 observations per person, weekly for the first 2 months, then monthly for 10 months. | |
Primary | Mean Waist Circumference Change Per Week From Baseline to Termination | Participants' waist circumference was measured at each visit by study personnel using a measuring tape, and the study groups' average waist circumference changes per week were compared. | Up to 19 observations per person, weekly for the first 2 months, then monthly for 10 months. | |
Primary | Mean Body Mass Index (BMI) Change Per Week From Baseline to Termination | Study personnel calculated each participant's BMI at each visit using their weight measurement taken at that visit and their height measurement taken at baseline. The study groups' average BMI changes per week were then compared. | Up to 19 observations per person, weekly for the first 2 months, then monthly for 10 months. | |
Primary | Mean Serum Insulin Level Change Per Week From Baseline to Termination | Results obtained through VA facility's Outpatient Lab. The study groups' average serum level changes per week were then compared. | Up to 5 observations per person, at baseline, 3 months, 6 months, 9 months, and 12 months. | |
Primary | Mean Triglycerides Level Change Per Week From Baseline to Termination | Results obtained through VA facility's Outpatient Lab. The study groups' average blood level changes per week were then compared. | Up to 5 observations per person, at baseline, 3 months, 6 months, 9 months, and 12 months. | |
Primary | Mean Low-Density Lipoprotein (LDL) Cholesterol Level Change Per Week From Baseline to Termination | Results obtained through VA facility's Outpatient Lab. The study groups' average blood level changes per week were then compared. | Up to 5 observations per person, at baseline, 3 months, 6 months, 9 months, and 12 months. | |
Primary | Mean High-Density Lipoprotein (HDL) Cholesterol Level Change Per Week From Baseline to Termination | Results obtained through VA facility's Outpatient Lab. The study groups' average blood level changes per week were then compared. | Up to 5 observations per person, at baseline, 3 months, 6 months, 9 months, and 12 months. | |
Primary | Health Knowledge Quiz Mean Total Score Change Per Week From Baseline to Termination | Quiz of information covered during Lifestyle Balance classes, score range 0 - 30, worst to best. The study groups' average score changes per week were then compared. | Up to 4 observations per person,at baseline, 2 months, 6 months, and 12 months. | |
Primary | Change in Mean Total Calories Consumed Per Week From Baseline to Termination | Caloric intake assessed by dietitians using participant-recorded weekly food and exercise journals. The study groups' average change in total calories consumed per week were then compared. | Up to 19 observations per person, weekly for the first 2 months, then monthly for 10 months. | |
Primary | Change in Mean Empty Calories Consumed Per Week From Baseline to Termination | Caloric intake assessed by dietitians using participant-recorded weekly food and exercise journals. The study groups' average change in empty calories consumed per week were then compared. | Up to 19 observations per person, weekly for the first 2 months, then monthly for 10 months. | |
Primary | Change in Mean Total Exercise Time Per Week From Baseline to Termination | Minutes exercised assessed by dietitians using participant-recorded weekly food and exercise journals. The study groups' average change in total minutes exercised per week were then compared. | Up to 19 observations per person, weekly for the first 2 months, then monthly for 10 months. | |
Primary | Mean University Rhode Island Change Assessment Scale (URICA) Total Score Change Per Week From Baseline to Termination | Self-reported survey of respondents' feelings about changing their weight problem. Total score is also called the Readiness Score, ranging from -2 to +14 (worse to better), calculated by subtracting the mean from the precontemplation responses from the summation of the means of responses to contemplation, action, and the struggling to maintain items. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. | |
Primary | WHO Quality of Life-BREF (WHOQOL-BREF) Mean Domain 1 Score Change Per Week From Baseline to Termination | Self-reported survey of quality of life as related to respondents' physical health, score range 7-35, worst to best. The study groups' average subscore changes per week were then compared. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. | |
Primary | WHO Quality of Life-BREF (WHOQOL-BREF) Mean Domain 2 Score Change Per Week From Baseline to Termination | Self-reported survey of quality of life as related to respondents' psychological health, score range 6-30, worst to best. The study groups' average subscore changes per week were then compared. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. | |
Primary | WHO Quality of Life-BREF (WHOQOL-BREF) Mean Domain 3 Score Change Per Week From Baseline to Termination | Self-reported survey of quality of life as related to respondents' social relationships, score range 3-15, worst to best. The study groups' average subscore changes per week were then compared. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. | |
Primary | WHO Quality of Life-BREF (WHOQOL-BREF) Mean Domain 4 Score Change Per Week From Baseline to Termination | Self-reported survey of quality of life as related to respondents' environment, score range 8-40, worst to best. The study groups' average subscore changes per week were then compared. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. | |
Primary | Brief Psychiatric Rating Scale (BPRS) Mean Total Score Change Per Week From Baseline to Termination | Clinician-assessed symptom survey, score range 18 - 126, best to worst. The study groups' average score changes per week were then compared. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. | |
Primary | Beck Anxiety Inventory (BAI) Mean Total Score Change Per Week From Baseline to Termination | Self-reported symptom survey, score range 0 - 63, best to worst. The study groups' average score changes per week were then compared. | Up to 4 observations per person, at baseline, 2 months, 6 months, and 12 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |